Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysis.
Journal: Haematologica
Published: February 20, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: a MIDAS consortium study.
Journal: Blood advances
Published: January 15, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study.
Journal: Blood advances
Published: January 15, 2026
Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT).
Journal: Bone marrow transplantation
Published: January 13, 2026
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.
Journal: Bone marrow transplantation
Published: December 18, 2025
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
Journal: medRxiv : the preprint server for health sciences
Published: December 17, 2025
Optimizing Patient Selection for Reduced Nonrelapse Mortality After Reduced-Intensity Conditioning: A CIBMTR Analysis.
Journal: Transplantation and cellular therapy
Published: September 25, 2025
Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia.
Journal: Transplantation and cellular therapy
Published: July 28, 2025
Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia.
Journal: Transplantation and cellular therapy
Published: July 27, 2025
Last Updated: 09/26/2026